Aug 31, 2020The FDA Authorizes Convalescent Plasma for Covid-19 UseVideo credit: wsj.com Food and Drug Administration authorized use of convalescent plasma, the antibody-rich blood component taken from recovered Covid-19 patients, for the treatment of serious coronavirus cases. Check out the article here.0 commentsPost not marked as liked
Video credit: wsj.com Food and Drug Administration authorized use of convalescent plasma, the antibody-rich blood component taken from recovered Covid-19 patients, for the treatment of serious coronavirus cases. Check out the article here.